A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).
Clinical trial NCT00768079 · COMPLETED
Trial details
- NCT number
- NCT00768079
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-02
- Primary completion
- 2010-12-17
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.